215 related articles for article (PubMed ID: 9723433)
1. Five-year follow-up of tacrolimus as primary immunosuppressant after liver transplantation.
Jonas S; Guckelberger O; Bechstein WO; Berg T; Müller AR; Platz KP; Tullius SG; Settmacher U; Steinmüller T; Hopf U; Neuhaus P
Transplant Proc; 1998 Aug; 30(5):2179-81. PubMed ID: 9723433
[No Abstract] [Full Text] [Related]
2. Tacrolimus (FK506)-based dual versus triple therapy following liver transplantation.
Samuel D; Bismuth H; Boillot O; Ducerf C; Baulieux J; Gugenheim J; Baldini E; Launois B; Messner M; Wolf P; Ellero E; Domergue J; Pageaux J; Cherqui D; Duvoux C; Durand F; Belghiti J; Calmus Y; Massault PP; Neau-Cransac M; Saric J; LeTreut Y; Campan P
Transplant Proc; 1998 Jun; 30(4):1394-6. PubMed ID: 9636563
[No Abstract] [Full Text] [Related]
3. FK506 for primary and rescue therapy following liver transplantation.
Platz KP; Mueller AR; Zytowski M; Lobeck H; Neuhaus P
Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570
[No Abstract] [Full Text] [Related]
4. Experience with neoral cyclosporine through the oral route in liver transplantation.
Bilbao I; Lazaro JL; Pou L; Charco R; Hildalgo E; Murio E; Margarit C
Transplant Proc; 1998 Jun; 30(4):1432-4. PubMed ID: 9636580
[No Abstract] [Full Text] [Related]
5. Ten-year results of a randomised prospective study of FK506 versus cyclosporine in management of primary orthotopic liver transplantation.
Chen JW; Pehlivan M; Gunson BK; Buckels JA; McMaster P; Mayer D
Transplant Proc; 2002 Aug; 34(5):1507-10. PubMed ID: 12176460
[No Abstract] [Full Text] [Related]
6. A prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients.
Fischer L; Sterneck M; Gahlemann CG; Malago M; Rogiers X; Broelsch CE
Transplant Proc; 2000 Nov; 32(7):2125-7. PubMed ID: 11120098
[No Abstract] [Full Text] [Related]
7. Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus).
Van Buren D; Payne J; Geevarghese S; MacDonell R; Chapman W; Wright JK; Helderman JH; Richie R; Pinson CW
Transplant Proc; 1998 Jun; 30(4):1401-2. PubMed ID: 9636566
[TBL] [Abstract][Full Text] [Related]
8. Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial.
Langrehr JM; Klupp J; Junge G; Jonas S; Neuhaus R; Bechstein WO; Neuhaus P
Transplant Proc; 2001 May; 33(3):2330-1. PubMed ID: 11377549
[No Abstract] [Full Text] [Related]
9. Conversion from tacrolimus to microemulsion formulation of cyclosporine in pediatric liver transplantation.
Alberti D; Reding R; Otte JB; Falchetti D; Rigamonti W; Caccia G; Sokal E; de Ville de Goyet J
Transplant Proc; 1998 Aug; 30(5):1858-60. PubMed ID: 9723310
[No Abstract] [Full Text] [Related]
10. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
Bilbao I; Pou L; Allende E; Lázaro JL; Charco R; Hidalgo E; Margarit C
Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472
[No Abstract] [Full Text] [Related]
11. Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection.
Kato T; Ruiz P; DeFaria W; Weppler D; Khan F; Pinna A; Nery J; Tzakis A
Transplant Proc; 1999; 31(1-2):396. PubMed ID: 10083158
[No Abstract] [Full Text] [Related]
12. Experience with the use of basiliximab in liver transplantation--use in pediatric and adult recipients in combination with cyclosporine or tacrolimus.
Petz W; Spada M; Bertani A; Lucianctti A; Casagrande F; Guizzetti M; Corno V; Colledan M; Strazzabosco M; Gridelli B
Transplant Proc; 2002 Aug; 34(5):1966-7. PubMed ID: 12176648
[No Abstract] [Full Text] [Related]
13. Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation.
Klupp J; Glanemann M; Bechstein WO; Platz KP; Langrehr JM; Keck H; Settmacher U; Radtke C; Neuhaus R; Neuhaus P
Transplant Proc; 1999; 31(1-2):1113-4. PubMed ID: 10083497
[No Abstract] [Full Text] [Related]
14. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H
Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
[No Abstract] [Full Text] [Related]
15. Steroid withdrawal in long-term liver transplant recipients.
Sterneck M; Fischer L; Weise C; Broering D; Rogiers X
Transplant Proc; 2001; 33(7-8):3265-7. PubMed ID: 11750398
[No Abstract] [Full Text] [Related]
16. Standard cyclosporine A-based versus completely steroid-free FK506-based immunosuppression after liver transplantation.
Pirenne J; Aerts R; Koshiba T; Van Gelder F; Roskams T; Nevens F; Fevery J
Transplant Proc; 2001; 33(1-2):1505. PubMed ID: 11267396
[No Abstract] [Full Text] [Related]
17. Early steroid withdrawal after liver transplantation.
Ramirez CB; Sebayel MI; Kizilisik T
Transplant Proc; 1998 Nov; 30(7):3182-3. PubMed ID: 9838406
[No Abstract] [Full Text] [Related]
18. Neoral is superior to FK 506 in liver transplantation.
Levy GA
Transplant Proc; 1998 Aug; 30(5):1812-5. PubMed ID: 9723293
[No Abstract] [Full Text] [Related]
19. Tacrolimus is effective in both dual and triple regimens after liver transplantation.
Serrano J; García González M; Gómez M; Ortiz de Urbina J; López Cillero P; San Juan F; Parrilla P; Herrero JI
Transplant Proc; 2002 Aug; 34(5):1529-30. PubMed ID: 12176469
[No Abstract] [Full Text] [Related]
20. Use of FK506 as primary or rescue therapy after liver transplantation in Hong Kong.
Lo CM; Fan ST; Liu CL; Chan KL; Ng IO; Lai CL; Lau GK; Fung SK; Wong J
Transplant Proc; 1998 Nov; 30(7):3587-8. PubMed ID: 9838571
[No Abstract] [Full Text] [Related]
[Next] [New Search]
